Comparison between 0.5% Ropivacaine and in combination with Dexmedetomidine for ultrasound guided Supraclavicular brachial plexus block for upper limb surgery.

Not Applicable

Completed

• Conditions: Health Condition 1: O- Medical and Surgical

• Registration Number: CTRI/2019/01/017309
• Lead Sponsor: JLN MEDICAL COLLEGE AJMER

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2018-06-15
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 100

Inclusion Criteria

Age group between 15 and 65 years.

Body weight 30 to 80 kg.

Patients belonging to ASA (American Society of Anaesthesiologists) class-I and II.

Patients undergoing upper limb surgeries of duration 1-2 hours in theatre with haemoglobin at least 9 gm/dl.

Patient free from any associated acute or chronic systemic illness.

Exclusion Criteria

Patients not willing to participate in the study.

Uncooperative patients.

Patient with chronic pain or on long-term analgesics.

Any known hypersensitivity or contraindication to ropivacaine, dexmedetomidine.

Local pathology at the site of injection or disability limiting the performance of block.

Patients receiving beta blockers or cardiac drugs.

History of convulsion, allergy to the drug used, bleeding disorder, severe neurological deficit, thyroid disorder.

Patient with history of respiratory, cardiac, hepatic or renal disease (necessitating classification in ASA Class III or above).

Patients having a history of significant neurological, psychiatric, or neuromuscular disorders.

Pregnant, lactating mothers.

Inadequate block necessitating institution of general anaesthesia for continuation of surgical procedure.

Study & Design

• Study Type: Interventional
• Study Design: Not specified